WebAug 17, 2024 · OSS, The Netherlands – Citryll today announced that the first healthy volunteer has been enrolled and dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of CIT-013. CIT-013 is a first in class humanized therapeutic antibody targeting Neutrophil Extracellular Trap (NET) formation and clearance. WebSep 13, 2024 · Citryll’s candidate CIT-013 is a tACPA therapeutic antibody targeting Neutrophil Extracellular Trap (NET) biology and is being developed as a potential treatment for various diseases including lupus, vasculitis, pulmonary fibrosis and organ damage due to sepsis. “We’re using existing technology to support Citryll including our established ...
Advisors – Citryll
WebShe is an Internist and a Rheumatologist. Her research focuses on characterizing the role of the innate immune system in the development of systemic rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis. Her lab has focused on the role of neutrophils and neutrophil extracellular traps in autoimmunity, chronic ... WebCitryll BV is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis … did ghostface have a baby by rza sister
Citryll enters into bioanalytics partnership with Ardena for the ...
WebCitryll BV is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. Target... WebJul 3, 2024 · Citryll is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. Citryll was... WebJul 14, 2024 · Citryll is a private pharmaceutical company based in Oss, the Netherlands at the Pivot Park and that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. did ghostface killah get shot